Joseph S. Shan
2013
In 2013, Joseph S. Shan earned a total compensation of $588K as Vice President, Clinical & Regulatory Affairs at Peregrine Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $88,725 |
|---|---|
| Option Awards | $193,410 |
| Salary | $270,200 |
| Other | $35,666 |
| Total | $588,001 |
Shan received $270.2K in salary, accounting for 46% of the total pay in 2013.
Shan also received $88.7K in non-equity incentive plan, $193.4K in option awards and $35.7K in other compensation.
Rankings
In 2013, Joseph S. Shan's compensation ranked 8,781st out of 12,286 executives tracked by ExecPay. In other words, Shan earned more than 28.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,781 out of 12,286 | 29th |
Division Manufacturing | 3,198 out of 4,612 | 31st |
Major group Chemicals And Allied Products | 1,017 out of 1,462 | 30th |
Industry group Drugs | 775 out of 1,156 | 33rd |
Industry Pharmaceutical Preparations | 614 out of 890 | 31st |
Source: SEC filing on August 28, 2014.
Shan's colleagues
We found five more compensation records of executives who worked with Joseph S. Shan at Peregrine Pharmaceuticals in 2013.
2013
Steven King
Peregrine Pharmaceuticals
Chief Executive Officer
2013
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2013
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2013
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
2013
Shelley Fussey
Peregrine Pharmaceuticals